Abstract
To assess Canadian physician concerns with, and barriers to the use of strong opioids in the treatment of moderate-to-severe chronic non-cancer pain (CNCP), an Omnibus telephone survey was conducted, interviewing a nationally representative sample of 100 family physicians. The results are compared to a similar study conducted in 2001. Of patients seen for CNCP, 67% have moderate-to-severe pain levels, unchanged from 2001 (65%). On average, physicians believe 27% of CNCP patients are unwilling to take opioid medications stronger than Tylenol 3’s, even when physicians believe patients would benefit.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
